Loading...

Cyclopharm Limited

CYC.AXASX
Healthcare
Medical - Devices
A$0.98
A$-0.06(-5.77%)

Cyclopharm Limited (CYC.AX) Company Profile & Overview

Explore Cyclopharm Limited’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Cyclopharm Limited (CYC.AX) Company Profile & Overview

Cyclopharm Limited manufacture and sells medical equipment and radiopharmaceuticals in the Asia Pacific, Europe, Canada, and internationally. It operates through Technegas and Molecular Imaging segments. The Technegas segment offers diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism. This segment also distributes third party products to the diagnostic imaging sector. The Molecular Imaging segment provides radiopharmaceuticals that are used by physicians in the detection of cancer, neurological disorders, and cardiac diseases. The company serves nuclear medicine departments. Cyclopharm Limited was founded in 1986 and is headquartered in Kingsgrove, Australia.

SectorHealthcare
IndustryMedical - Devices
CEOJames S. McBrayer AIM, BSPharm, FAICD, GDM

Contact Information

61 2 9541 0411
1 The Crescent, Kingsgrove, NSW, 2208

Company Facts

95 Employees
IPO DateJan 17, 2007
CountryAU
Actively Trading

Frequently Asked Questions

;